Site notifications

Sub menu

 
 

​Cisplatin Injection BP 100mg/100mL (1mg/mL) Solution for Intravenous Infusion, single use vial (Hikma, Canada)​

Section 19A approved medicine
​Cisplatin Injection BP 100mg/100mL (1mg/mL) Solution for Intravenous Infusion, single use vial (Hikma, Canada)​
Section 19A approval holder
ORSPEC Pharma Pty Ltd ABN 15 634 980 417
Phone
02 4339 4239
Approved until
Status
Current
Medicines in short supply/unavailable
DBL CISPLATIN 100mg/100mL injection vial - ARTG 47276
CISPLATIN ACCORD cisplatin 100 mg/100 mL concentrated injection vial - ARTG 286791
CISPLATIN ACCORD cisplatin 50 mg/50 mL concentrated injection vial - ARTG 286786
Indication(s)

Cisplatin may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:

  • Metastatic non-seminomatous germ cell carcinoma
  • Advanced stage, refractory ovarian carcinoma
  • Advanced stage, refractory bladder carcinoma
Related medicines shortage notifications
https://apps.tga.gov.au/Prod/msi/Search/Details/cisplatin
Images
Picture of Cisplatin Injection BP 100mg in 100mL Solution for Intravenous Infusion vial - carton

Help us improve the Therapeutic Goods Administration site